Boston Scientific Corporation
NYSEBSX cost to borrow doubles in one week to 0.614%, rising sharply as analyst targets reset lower following earnings.
Boston Scientific has just reported Q2 earnings today — and the stock's 6.6% rally on the week tells only part of the story, because analysts are still cutting targets even as they hold their Buy ratings. The analyst…
Boston Scientific heads into its July 29 earnings report with analysts uniformly bullish but equally unanimous in cutting their expectations — a disconnect that puts the quality of the actual numbers front and…
Snapshot as of 6 Aug 2026
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BSX — free to start on ORTEX.
Sign up for free →Open BSX on ORTEX